124916-54-7 Usage
Complex structure
Chromen-4-yl and isoindolone groups
The compound has a complex structure consisting of two main parts
a chromen-4-yl group and an isoindolone group, both of which are important in pharmaceutical research.
Stereochemistry
(3S,4R)
The stereochemistry of the compound is specified as (3S,4R), which indicates the spatial arrangement of the atoms and the configuration of the molecule.
Trifluoromethoxy substituent
6-position
The chromen-4-yl group has a trifluoromethoxy substituent at the 6-position, which can influence the compound's pharmacological properties and potential applications.
Hydroxy group
3-position
The chromen-4-yl group also has a hydroxy group at the 3-position, which can contribute to the compound's polarity and solubility.
2,3-Dihydro-1H form
Isoindolone group
The isoindolone group is in the 2,3-dihydro-1H form, which affects the compound's structure and may have implications for its pharmacological properties.
Potential medicinal applications
Pharmaceutical research
The structural features of the compound make it potentially useful for medicinal purposes, although further research is needed to fully understand its pharmacological properties and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 124916-54-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,9,1 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 124916-54:
(8*1)+(7*2)+(6*4)+(5*9)+(4*1)+(3*6)+(2*5)+(1*4)=127
127 % 10 = 7
So 124916-54-7 is a valid CAS Registry Number.
124916-54-7Relevant articles and documents
Antihypertensive benzopyran derivatives
-
, (2008/06/13)
Disclosed herein are novel benzopyrans represented by formula (I) STR1 wherein R1 is trifluoromethoxy or β, β, β-trifluoroethoxy; R2 and R3 are independently selected from the group consisting of hydrogen, lower alkyl containing 1 to 5 carbon atoms, cyclo lower alkyl containing 5 to 8 carbon atoms, STR2 or R2 and R3 are joined to form (--CH2 --)n wherein n is 4 to 7; or R2 and R3 are joined together to form (--CH2 --)m CO-- wherein m is 3 to 6; or R2 and R3 are joined together to form STR3 wherein R4 is selected from the group consisting of hydrogen, alkoxy containing 1 to 5 carbon atoms, amino or mono- or disubstituted alkyl amino wherein said alkyl groups contain 1 to 5 carbon atoms and the pharmaceutically acceptable salts and solvates thereof, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in the treatment of hypertension, asthma, irritable bladder syndrome, and irritable bowel syndrome.
